
|Articles|November 15, 2002
Bone marrow-derived stem cells show potential for treating retinal diseases
La Jolla, CA-Results from murine studies indicate that a population of adult bone marrow-derived hematopoietic stem cells injected intravitreally will selectively target activated astrocytes, become incorporated into blood vessels, and promote or inhibit retinal angiogenesis, reported Martin Friedlander, MD, PhD.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
























